SCPC Applauds President Trump’s Executive Order Calling on HHS and Congress to Improve the IRA, Rein In PBMs and Lower Drug Costs
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement applauding President Trump’s recent Executive Order aimed at improving the Inflation Reduction Act (IRA), lowering drug prices and addressing the harmful actions of PBMs.
“For far too long, pharmacy benefit managers (PBMs) have taken advantage of the lack of transparency in our healthcare system, establishing monopolistic control over the delivery of pharmacy services and significantly increasing what Americans pay for prescription medications. Anticompetitive PBMs practices have created a healthcare crisis, threatening the survival of pharmacies, including those that provide essential services to millions of patients in long-term care.”
“We commend President Trump’s efforts to address harmful PBM behavior by restoring competition, ensuring fair contracting and promoting transparency in our healthcare system. We encourage leaders in Congress—especially those who have already been championing PBM reform—to heed the President’s call for action and deliver meaningful reform that protects LTC pharmacies and the millions of seniors they serve.”
“LTC pharmacies are uniquely impacted by both aggressive PBM actions and recent Medicare Part D drug pricing policy changes included in the Inflation Reduction Act (IRA) that threaten the viability of many essential pharmacies across the country. The current Medicare pharmacy payment model is broken and forces LTC pharmacies to dispense medicines at a loss while PBMs and Part D plans reap massive profits. This problem will only worsen when new Medicare negotiated drug prices take effect in January 2026.”
“While there are many details for Congress to consider, Members must quickly follow through on President Trump’s Executive Order to protect seniors’ access to medicines and essential pharmacy services. We look forward to working with the White House, HHS and Congressional leaders to establish meaningful policy solutions that ensure the continued delivery of quality long-term care, support continued pharmaceutical innovation and protect the needs of America’s most vulnerable patients.”
Statement should be attributed to Alan Rosenbloom, President and CEO of SCPC.
###
Recent Posts
-
House Lawmakers Push Bipartisan IRA Fix To Boost LTC Pharmacy Pay
A bipartisan group of House lawmakers introduced legislation aimed at ensuring long-term care (LTC) pharmacies are paid an adequate supply fee to maintain patient access to prescription drugs for which prices are lowered through the Medicare drug price negotiation program, with the new maximum fair prices (MFPs) for the first group of selected drugs to take effect at the start of 2026.
-
Bill would fix drug-negotiation pricing flaw that undercuts LTC pharmacists’ viability
Lawmakers have proposed a supply fee to bolster long-term care pharmacies facing major revenue losses with the implementation of negotiated prices on 10 commonly prescribed medications Jan. 1.
The Preserving Patient Access to Long-Term Pharmacies Act establishes a $30 per Medicare Part D prescription in 2026 and 2027.
-
Rep. Van Duyne Introduces Bipartisan Legislation to Protect Seniors’ Access to Long-Term Care Pharmacies
Washington, D.C. – Representatives Beth Van Duyne (R-TX), Brad Schneider (D-IL), Buddy Carter (R-GA), Sharice Davids (D-KS), and Deborah Ross (D-NC) introduced H.R. 5031 Preserving Patient Access to Long-Term Care Pharmacies Act, bipartisan legislation to protect access to essential medications and pharmacy services for seniors and other long-term care (LTC) residents in nursing homes, assisted living, and similar […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.